Investors Encouraged to Lead Class Action Against Outset Medical Amid Securities Fraud Claims

LOS ANGELES, Oct. 25, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) is calling on investors who have incurred significant losses to step forward and take the lead in a securities fraud class action against Outset Medical, Inc. (“Outset Medical” or the “Company”) OM.

Class Period: September 15, 2020 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024

Interested parties wishing to lead the class action against Outset Medical can share their details at www.glancylaw.com/cases/Outset-Medical-Inc-1/. For further information, reach out to Charles H. Linehan at GPM by calling 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected].

The lawsuit claims that during the Class Period, Outset Medical failed to inform investors about important issues. These include: (1) the Tablo devices were marketed for uses not approved by the FDA; (2) the likelihood of the Company needing to seek additional FDA approvals for the Tablo products; (3) the risk that sales of the Tablo products would halt pending these approvals; (4) the inadequate sales team the Company possessed to effectively grow Tablo sales; (5) the adverse impact on the Company’s revenue growth due to these issues; and (6) misleading statements made by the Company regarding its business outlook and operations.

Stay informed about updates through LinkedIn, Twitter, or Facebook.

To be part of this class action, no immediate steps are necessary. Participants can choose their own legal representation or remain an absent member of the case. For questions about this class action or to understand your rights connected to the pending lawsuit, you can contact Charles Linehan, Esquire at GPM, located at 1925 Century Park East, Suite 2100, Los Angeles, California 90067. He can be reached at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected]. When emailing, please include your mailing address, phone number, and the number of shares purchased.

This press release might be seen as Attorney Advertising in certain jurisdictions based on applicable laws and ethical standards.

Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
[email protected]
www.glancylaw.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/om-investors-have-opportunity-to-lead-outset-medical-inc-securities-fraud-lawsuit-302286822.html

SOURCE Glancy Prongay & Murray LLP